九典制药
(300705)
| 流通市值：37.55亿 | | | 总市值：50.78亿 |
| 流通股本：3.70亿 | | | 总股本：5.00亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 2,048,723,120.08 | 1,286,839,471.27 | 595,244,012.8 | 3,110,900,254.23 |
| 营业总成本 | 1,777,471,633.03 | 1,119,470,663.56 | 540,618,256.72 | 2,579,938,093.88 |
| 其他经营收益 | | | | |
| 营业利润 | 290,014,296.43 | 181,136,876.35 | 61,103,211.41 | 537,742,462.11 |
| 利润总额 | 280,636,835.25 | 179,636,894.02 | 61,028,509.21 | 526,360,999.21 |
| 净利润 | 230,893,034.33 | 155,110,014.44 | 54,262,262.4 | 470,035,433.44 |
| 每股收益 | | | | |
| 其他综合收益 | 0 | 0 | 0 | 0 |
| 综合收益总额 | 230,893,034.33 | 155,110,014.44 | 54,262,262.4 | 470,035,433.44 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,737,892,297.83 | 1,539,944,637.71 | 1,545,003,521.99 | 1,539,290,374.58 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,657,493,214.47 | 2,638,173,511.12 | 2,574,773,071.89 | 2,479,545,310.92 |
| 资产总计 | 4,395,385,512.3 | 4,178,118,148.83 | 4,119,776,593.88 | 4,018,835,685.5 |
| 流动负债: | | | | |
| 流动负债合计 | 714,667,716.01 | 574,565,739.35 | 414,090,370.87 | 422,444,923.08 |
| 非流动负债: | | | | |
| 非流动负债合计 | 857,108,474.64 | 855,716,545.74 | 864,428,098.14 | 810,163,010.87 |
| 负债合计 | 1,571,776,190.65 | 1,430,282,285.09 | 1,278,518,469.01 | 1,232,607,933.95 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,676,164,550.29 | 2,595,933,913.64 | 2,693,345,154.25 | 2,658,840,945.19 |
| 股东权益合计 | 2,823,609,321.65 | 2,747,835,863.74 | 2,841,258,124.87 | 2,786,227,751.55 |
| 负债和股东权益合计 | 4,395,385,512.3 | 4,178,118,148.83 | 4,119,776,593.88 | 4,018,835,685.5 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,158,631,630.17 | 1,417,320,343.67 | 646,836,151.74 | 3,195,580,322.42 |
| 经营活动现金流出小计 | 1,678,322,332.44 | 1,109,869,589.44 | 568,961,363.07 | 2,548,522,755.96 |
| 经营活动产生的现金流量净额 | 480,309,297.73 | 307,450,754.23 | 77,874,788.67 | 647,057,566.46 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,013,023,205.17 | 612,354,133.21 | 301,875,658.51 | 648,221,323.1 |
| 投资活动现金流出小计 | 1,402,773,776.92 | 828,896,252.28 | 373,866,164.57 | 1,281,431,708.61 |
| 投资活动产生的现金流量净额 | -389,750,571.75 | -216,542,119.07 | -71,990,506.06 | -633,210,385.51 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 258,385,899.83 | 183,947,999.58 | 46,550,000 | 283,669,956.23 |
| 筹资活动现金流出小计 | 271,811,411.47 | 252,364,916.57 | 6,359,500.51 | 278,779,669.03 |
| 筹资活动产生的现金流量净额 | -13,425,511.64 | -68,416,916.99 | 40,190,499.49 | 4,890,287.2 |
| 汇率变动对现金及现金等价物的影响 | -130,316.96 | -86,168.04 | -38,261.67 | -57,106.08 |
| 现金及现金等价物净增加额 | 77,002,897.38 | 22,405,550.13 | 46,036,520.43 | 18,680,362.07 |
| 期末现金及现金等价物余额 | 529,202,612.84 | 474,605,265.59 | 498,236,235.89 | 452,199,715.46 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 22,405,550.13 | - | 18,680,362.07 |
最新报告期：2026-08-24| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 平安证券 | 叶寅,韩盟盟 | 0.64 | 0.76 | 0.94 | 2026-08-24 |